Document vyYNRjzbG9ozYmQ4X8wd7En2Z

CHEMICAL MANUFACTURERS ASSOCIATION 5 * . r<^ : June 30, 1986 TO: HEALTH AND SAFETY CONTACTS Enclosed is the first issue of the Health and Safety Newsletter, a quarterly publication of CMA's Health and Safety Committee. It includes valuable information con cerning regulatory developments and Congressional and Administration action affecting the chemical manufacturing industry in addition to pertinent activities of Health and Safety Committee task groups. For additional information on any item, contact the specified individual. As Editor of the Newsletter, I welcome your comments and suggestions. Please feel free to contact me at 202/887-1365. Sincerely, MRH:mdm Marion R. Herz Manager Health, Safety and Chemical Regulations BOR 007574 received -'CL. ? 1986 DAr,,MMW Formerly Manufacturing Chemists Association--Serving the Chemical Industry Since 1872. 2501 M Street, NW Washington, DC 20037 Telephone 202/887-1100 Telex 89617 (CMA WSH) XJEALTH SCAiETY JL JL TJj W NEWSLETTER VOL. I NO. 1 CHEMICAL MANUFACTURERS ASSOCIATION 2501 M str*t NW Washington DC 20037 202/M7-1100 gkp June 1986 EPA ISSUES INVENTORY UPDATE REPORTING RULE FOR EXISTING CHEMICALS The EPA Administrator has signed a rule under the Toxic Substances Control Act (TSCA) that will require r porting for chemical substances listed on the TSCA Inventory of Chemicals in Commerce. For chemicals subject to reporting, the rule will require that com panies report production volume, plant site location, and use information. As explained further below, the rul includes exemptions for certain small companies and certain classes of substances. EPA published the final rule in the Federal Register on June 12,1986 (51 Fed. R g. 21438). Reports will be due by December 23, 1986. Substances covered by the rule include those originally reported for the Inventory as well as those subsequently added after PMN review and receipt of a notice of commencement of manufacture or import. The following substances are excluded from the rule: polymers, inorganic substances, microorganisms, and naturally occuring chemical substances. In addition, substances manufactured or imported at less than 10,000 pounds per year at a plant site will be exempt from reporting at that site. Companies will be exempt from the rule if they are small manufacturers who satisfy either of two stan dards: 1) total annual corporate sales of less than $40 million and total site-specific production volume (or total amount imported) of a substance below 100,000 pounds per year, or 2) total annual corporate sales of less than $4 million. The last group eligible for exemption is companies that manufacture or import chemical substances in limited circumstances or through coincidental manufacture, for example, manufacture or import of substances for research and development, as non isolated intermediates, or as impurities or by-products with no separate commercial intent. The initial reporting will occur within 120 days after the beginning of the reporting period. The designat d time for recurring r porting is four years after the first reporting period and v ry four y ars thereafter. These reporting periods will b 120 days, also. For further information concerning the final Inven tory update rule, review the Federal Register notice. Instruction booklets, reporting forms, and answers to questions can be obtained by calling EPA's sp cial hotline at 202/382-3698 or 202/755-4880. CMA Contact: R. Garrity Baker, 202/887-1280 BUREAU OF LABOR STATISTICS ISSUES NEW GUIDELINES New Bureau of Labor Statistics (BLS) R cord keeping Guidelines for Reporting Occupational In juries and Illnesses, which went into effect on April 24, 1986, contain clarifications, including that injuri s incurred in company-owned parking lots and on company-owned athletic facilities are no longer con sidered work related injuries. The Safety Programs Task Group (SPTG) is plan ning a seminar in conjunction with OSHA and the Bureau of Labor Statistics to address injury and illness recordkeeping and reporting requirements under the new Guidelines. Scheduled for September, th seminar will feature OSHA and BLS professionals dis cussing issues (provided in advance by m mbers of the chemical industry) relating to reportability, enfor cement and interpretation. In addition, the new Guidelines will be compared to the old BLS 412 Guidelines. The SPTG has created a work group which will solicit potential discussion items from CMA mem bers and submit them to the agencies. This seminar will provide an opportunity for industry to obtain clarification and elaboration on critical points. The Guidelines, coupled with OSHA's pres nt emphasis on recordkeeping, should be requir d read ing for every company officer responsibl for reporting workplace injuries. CMA Contact: Kyle B. Olson, 202/887-1275 BOR 007575 WORKER NOTIFICATION BILL SCHEDULED FOR EDUCATION AND LABOR COMMITTEE MARKUP ' Congressman Gaydos' (D-PA) "High Risk Oc cupational Disease Notification and Prevention Act" (H.R. 1309, as amended) was reported out of a Sub committee of the Education and Labor Committee on May 14. It is anticipated to be reported to the House floor by the full Committee at a markup scheduled for later this month. H.R. 1309 proposes new legislation to identify and individually notify past and present workers who are at elevat d risk for contracting an occupational disease due to a hazardous occupational exposure. The bill uses an arbitrary triggerto identify worker populations at risk. According to the trigger, if the incidence of associated disease in an exposed worker population is 30 percent more than the incidence of the same dis- as in a non-exposed population, the exposed pop ulation would be labeled at risk. Although CMA supports the general objectives of this legislation, which are to identify increased risks and facilitate prompt intervention, the Association opposes specific provisions of H.R. 1309, as stated in CMA's on October 9,1985 testimony before the Sub committee on Health and Safety of the Committee on Education and Labor: The arbitrary trigger of 30 percent excess incidence of disease to identify workers at risk is scientifically unsound and unsupportable. The bill does little more than duplicate stan dards already in force under OSHA's Hazards Communication Standard and the Employee Exposure and Medical Records Access Rule. On May 15, the Senate Subcommittee on Labor h Id a hearing on Senator Metzenbaum's(D-OH) com panion legislation (S. 2050), which is similar to H.R. 1309, as amended. CMA submitted a statement for the r cord in opposition to the Metzenbaum proposal, reit rating similar concerns expressed in testimony on H.R. 1309. Congressman Petri (R-WI) recently introduced H.R. 4793, the Republican substitute for the Gaydos bill, which builds upon the existing OSHA Hazards Communication Standard. The bill expands the scoo^k of the Standard to the non-manufacturing sector a^p further requires that employers notify former em ployees whose addresses are known of the health hazards present in the employees' work area during their employment. CMA is working with others in the business community to achieve consideration of the Petri substitute as the Gaydos bill moves through the House. CMA Contact: Lori M. Ramonas, 202/887-1384 ADMINISTRATION RELEASES BIOTECHNOLOGY POLICY Aftertwo years of study, the White House r leased its program for federal regulation of biot chnology products on June 18,1986. The overall ag ncy plan, titled "Coordinated Framework for Regulation of Biotechnology", maps out agency jurisdiction over biotechnology products. The first part of the plan was issued by the Administration in Novemb r 1985, pro viding for the establishment of an interagency review panel to discuss cross-cutting scientific issues and share regulatory information. ^ EPA's policies that apply to microbial products subject to TSCA or FIFRA include the following requirements: Microorganisms deliberately formed to con tain genetic material from dissimilar source organisms (inter-generic) will be subject to review before any environmental release, in cluding small-scale field testing and oth r environmental research and developm nt. EPA is considering a rule to exempt certain contained areas. Microorganisms formed by genetic engineer ing and other inter-genetic combinations will be subject to the following provisions: (a) If any source organism is a pathogen, th resulting microbial products are subject to r view prior to any environmental release except if us d solely for non-pesticidal agricultural uses, which are subject only to USDA review; (b) If source organisms are not pathogens, the resulting microbial products will be subject to BOR 007576 2 > l abbreviated review before any small-scale environmental release. Non-engineered microorganisms: (a) Indignous pathogens will be reviewed prior to use on greater than 10 acres of land and greater than one acre of water, except those that are solely for non-pesticidal agricultural purposes; (b) Nonidigenous pathogens will be reviewed under FI FRA for any environmental release, and underTSCA prior to release at greater than 10 acres; nonindigenous microorganisms that are not pathogen will be subject to abbreviated review before any small-scale environmental release. Microorganisms containing genetic material from other microorganisms in the same genus (products of d lib rate intra-generic combinations) and those developed from a single source microorganism (pro ducts of undirected mutagenesis, microorganisms with deletions) will be considered "new" for regulatory purposes. This policy may be revised, however. Th Subcommittee on Natural Resources, Agricul ture Research and Environment and the Subcommit tee on Science, Research and Technology of the House Committee on Science and Technology held joint h arings on June 4 and 5,1986, on H.R. 4452, the "Biot chnology Science Coordination Act of 1986", to regulat certain products of the biotechnology indus try. Major topics of discussion during the hearings w re: Risk Assessment --- What are the risks as sociated with biotechnology and how should they be assessed? Is liability insurance avail able to- or should it be required for- companies involved in this field? Precise definitions of the terms "release into the environment" and "genetically enginered organism" Th committee plans further hearings on this bill and th Administration policy. CMA Contact: Marion R. Herz, 202/887-1365 EPA POSTPONES EFFECTIVE DATE OF R & D REGULATION EPA recently postponed for sixty days th effec tive date of the final rule that defines research and development activities on new chemicals that are exempt from premanufacture notification und r the Toxic Substances Control Act. EPA published th rule in the Federal Register on April 22 (51 Fed. Reg. 15096), and it was to take effect June 5. With the 60 day extension, the effective date of the final r gulation is now Monday, August 4. Risk Evaluation The new final rule places several conditions on research and development without PM Nr vi w. First, it requires that companies evaluate the potential risks of substances manufactured for R & D purposes. The rule recognizes the special situation faced in labo ratory research. For laboratories, the rule allows the use of prudent laboratory practices for handling new substances in lieu of risk evaluation. Outside of th laboratory setting, however, companies will be r quired to evaluate the risks of R & D substances. They will be required to review information in their posses sion and control and information on health ff cts which accompanies any EPA rule or ord r issued under TSCA sections 4,5, or 6. Notification Companies must notify persons involved with R & D of any potential health risks associated with th sub stance. This notification requirement extends to per sons who are involved in experimentation, research, or analysis on the R & D chemical, including manufacture, processing, use, transport, storage, and disposal. Persons employed the manufacturers and to whom the company directly distributes the R & D substanc must be notified. For distribution outside the com pany, the manufacturers must notify in writing that the substance is to be used only for R & D purpos s and provide the notice of health risks. BOR 007577 3 R cordkeeping i Manufacturers and importers of R & D substances must keep records of certain information for five years to document compliance with the rule. Companies must keep records of: 1) the information reviewed and evaluated to perform the required risk evaluation; 2) the nature and method of the required notification, including copies of labels or written notices; 3) the pru dent laboratory practices used in lieu of the required risk evaluation; 4) the names and addresses of per sons outside the company to whom the substance is distributed, the identity of the substance, the amount distributed, and copies of required notifications; and, 5) for substances produced or imported in excess of 100 kilograms per year, additional records must be kept of the identity of the substance, the production volume, and the person's disposition of the sub stance. In the coming weeks, CMA member companies should review the final rule and bring their R & D activiti s into compliance with the requirements of the rule. CMA Contact: R. Garrity Baker, 202/887-1280 LABELING TASK GROUP REVISES ANSI LABELING STANDARD that time, the Labeling Task Group will canvas^ organizations targeted to have appreciable interest in the development of the Standard. Through a consen sus procedure involving formal vote by the organi zations, a final Standard will be developed for pub lication by the American National Standards Institute in 1987. CMA Contact: Nancy G, Doerrer, 202/887-1282 CHANGES PROPOSED FOR NEW CHEMICAL FOLLOW-UP PROGRAM CMA is participating in a consensus proj ct to improve the new chemical follow-up program in EPA's Office of Toxic Substances (OTS). Th project was begun by the Conservation Foundation's Toxic Sub stances Dialogue Group, a multi-partite consensus group formed to address issues in implentation of the Toxic Substances Control Act (TSCA). The Dialogue Group proposed that EPA develop a r gulatory mechanism to follow and, where nec ssary, control the commercial development of new chemicals thaL have been through the premanufacture notitifl (PMN) program. ^ The primary role of the CMA Labeling Task Group is to represent the Chemical Manufacturers Associa tion as Secretariat for the revision of the "American National Standard for the Precautionary Labeling of Hazardous Industrial Chemicals" (ANSI 2129.1). Since OSHA issued the Hazard Communication Stan dard, this project has become increasingly important to CMA member companies as an industry consensus on risk communication in the workplace. Inthe 1987 Standard, the LabelingTaskGroupwill suggest labeling language for physical, acute, and chronic hazards, and will recommend precautionary labeling for environmental storage and disposal of industrial chemicals. A selection of symbols for acute and physical hazards may also be incorporated in the Standard, depending upon the results of an industrial field test to determine which symbols are most effec tive in conveying an intended message. It is projected that the first draft of the 1987 Stan dard will be available for review in the fall of 1986. At EPA and the Dialogue Group are holding public meetings to develop a TSCA significant new us rule that will implement the Dialogue Group's proposal. As envisioned by the Dialogue Group, the significant n w use rule (SNUR) would apply to two groups of chemicals in the PMN review program. The first group consists of those chemicals that are subject to section 5(e) orders in the course of PMN review. The second group that would be subject to the SNUR consists of those chemicals for which the PMN use does not pose a problem but for which increases in exposure would raise EPA's risk concern. For substances subject to the SNUR, th rul would require notice to EPA before companies under take activities that are prohibited by the SNUR. Thus, the rule has a direct impact on the commercial development of new chemicals. Basic issues that need to be addressed are how to select chemicals for the SNUR and what use restrictions to place up upon selected chemicals. For the two groups of substances subject to the SNUR, the answer to these issu s is different. BOR 007578 4 For 5(e) chemicals, selection is not an issue because they are candidates for the SN UR by virtue of the 5( ). Similarly, the restrictions imposed by the SNUR will mirror the restrictions of the 5(e) order. In ff ct, the SNUR will extend the 5(e) order to all manufacturers and processors. Selection is more complex an issue for the new substances which are not subject to a 5(e) order but for which EPA has a concern. EPA and the Dialogue Group are working to develop criteria for health and environmental effects that could be used to select these substances. For the restrictions on these sub stances, the Dialogue Group is working to develop a list of major use changes that could significantly increas exposure. For example, off-site use in a case where the PMN specified a site-limited use. The rule will also establish procedures for making substances subject to the rule and for petitioning EPA to change the provision of the SNUR. Because of the important precedent of this rule, all CMA members should review the upcoming drafts that will be publicly available. CMA Contact: R. Garrity Baker, 202/887-1280 SERIOUS INCIDENT: REACTION OF CHLOROSULFONIC ACID AND HEPTANE Eastman Kodak Company issued a report to the chemical industry for educational purposes, describ ing an unexpected reaction of which little documenta tion had previously appeared in literature. We urge you to share this report with the proper personnel in your company. A 592 gallon chlorosulfonic weigh tank ruptured violently causing considerable damage to equipment, piping, and the building structure. There were no injuries to personnel. It was estimated that it would requir a minimum of 80 psi in the weigh tank to reach the yield point of the steel tank. It was also estimated that a force of 85,000 pounds was necessary to cause the three-and-one-half inch upward deflection of the 18-inch roof beam caused by the rocketing weigh tank. The weigh tank is used to provide a continuous m asured feed to a batch chlorination reaction. It is filled by direct pumping from a storage tank in yard. The last filling of the weigh tank emptied th storage tank resulting in sludge from the bottom of the storage tank entering the weigh tank. The weigh tank feeds by gravity into the reactor and the sludge plugged the lines preventing complete emptying of the weigh tank. After the batch was completed and the reactor emptied of product attempts were made to cl an the lines with nitrogen, but after several attempts, there still remained approximately 50 gallons of chlorosulfonic acid in the weigh tank. The normal practice for cleaning the weigh tank and associated piping is to wash with a commercial grade heptane until all chlorosulfonic acid is removed and then wash the tankand piping with water. This pro cedure had been performed many times without in cident. It was decided to wash the sludge from the weigh tank with heptane, and when 33 gallons of heptane had entered the weigh tank through a bottom outlet, an unexpected reaction occurred. The reaction created sufficient pressure to overcome the one-andone-half inch relief line and overpressure the vess I. After eliminating the possibilities of contamination by water, alcohols, etc., laboratory work discover d that a vigorous reaction occurred between heptane and chlorosulfonic acid that would create enough gas to overpower the relief valve and overpr ssure the vessel. Apparently, this reaction is not well known and has limited documentation in literature. Kodak's experi mental work, however, confirmed the reacti n with commercial heptane and chlorosulfonic sludge as w II as with dry n-heptane and reagent grad chloro sulfonic acid. CMA Contact: Kyle B. Olson, 202/887-1275 HAZARD ASSESSMENT TASK GROUP ADDRESSES REPRODUCTIVE EFFECTS AND CARCINOGENICITY The Hazard Assessment Task Group (HATG) acts to provide toxicological and regulatory expertise in the development and advocacy of CMA positions on hazard identification, test requirements and method ologies, and interpretation of toxicological studies. BOR 007579 5 I I Current testing efforts of the HATG focus on two chronic hazard areas: reproductive/developmental effects and carcinogenicity. The task group com missioned a report on a proposed tier system for developmental toxicity evaluations. The paper, to be submitted for publication in Teratology, describes a tier approach that markedly reduces the time and cost of dev lopmental toxicity evaluations, and reduces the number of animals normally required for routine in vivo tests. The system makes use of recently devised in vitro assays to quantitatively rank chemicals accord ing to their developmental hazard index, in conjunc tion with appropriate exposure considerations. The Hazard Assessment Task Group hopes to promote the use of this approach in future EPA test rule proposals and in the Agency's reproductive/developmental test guid lines review. A second major effort has been in the area of car cinogenicity. A joint industry association group has b n formed under the HATG to provide scientific input at several upcoming meetings of the Inter national Agency for Research on Cancer (IARC). Dr. L. Tomatis, Director of IARC, has invited CMA to provide critical comments to an IARC Committee prior to a planning meeting in September 1986. The intent of the m eting is to review lARC's scientific criteria for making carcinogen evaluations. With industry input from CMA, AIHC, PMA, NACA and API, Ian C. Munro, Ph.D., of the Canadian Centre for Toxicology is writing a document addressing the scientific criteria for car cinogen evaluations. In another series of meetings in late 1986 and early 1987, IARC will evaluate a list of 200 chemicals/ exposures for activity in short-term tests and for car cinogenic risk to humans based on experimental and epidemiological data. CMA has been invited to nominate an observer to these meetings. The joint industry association group is currently planning a method by which CMA member companies will pro vide chemical-specific carcinogenicity evaluations in advance of these IARC meetings. The CMA observer will th n be briefed and trained to represent to the IARC Committee scientific issues of concern to the industry. CMA Contact: Nancy G. Doerrer, 202/887-1282 CMA AIR TOXICS EFFORT INCORPORATE MANY GROUPS The Safety Programs Task Group (SPTG) is ad dressing the management of the acute emissions por tion of CMA'sAirToxics Control Policy implementation project. Working in conjunction with the Environmen tal Management Committee and an ad hoc group of communications professionals, the SPTG will compile guidance materials that address the elimination of uncontrolled air releases. This activity is designed to fulfill the commitment made by the Chemical Manufac turers Association earlier this year to identify and, to the extent feasible, reduce emissions into the at mosphere. The SPTG is coordinating the labors of several groups, including the Hazard Assessment, Risk As sessment, and Process Safety Task Groups, and the Engineering Advisory Committee. Th end product will be a compilation of documents that can b us dby a plant manager or a designee to evaluat existing air release problems and formulate responses to them. Among the materials being prepared: a discus sion of risk assessment methodologies, a r view of current lists of hazardous materials and suggesting of how the plant manager can use them, a of commlP cially available training programs as well as xamples of internally developed training courses, and a discus sion of administrative and engineering measures for reducing the chance of accidental releas s into the air. CMA Contact: Kyle B. Olson, 202/887-1275 B0S 007S80 6 CAER GROWS IN NUMBERS, ACTIVITIES CMA's Community Awareness and Emergency R sponse (CAER) program continues to grow. One hundr d forty-five CMA member companies have identifi d more than 1400 sites currently active in the program. CAER is also gaining advocates outside the Ch micai Manufacturers Association. The Chamber of Commerce of the U.S., the Metal Finishing Suppliers Association, the Chlorine Institute, the American Trucking Association, and the Synthetic Organic Chemical Manufacturers Association have endorsed the program and are encouraging their members to impl ment it. The CAER Task Group has established several projects to assist companies and communities in implementing the program: The task group is developing an Emergency Response Drill Training Module booklet and other course materials that will help com munities conduct emergency response simu lations to test their contingency plans. The task group has prepared three videotapes describing the CAER program, how to stablish a community coordinating group, and how to work with the media A National CAER Conferenc , held in Washington, D.C. addressed subjects includ ing the preparing of a site emergency response plan; establishing inter-industry coordination at the local level and how to work with your state chemical industry organizations; ap proaching local government to set up com munity coordinating groups; involving the media in local emergency response planning; and actual experiences in conducting com munity drills. CMA continues to work with state organizations to implement the CAER program. Proposals for specific programs to help state CICs have come from FI rida, Michigan, New Jersey, Ohio, and Texas. Programs will focus on first responder training workshops, develop ing CAER brochures, and activities designed to reach small communities and other manufacturers and users of chemicals. CMA Contact; D. Chris Cathcart, 202/887-1265 Joseph B. Kelley, 202/887-1150 HEALTH AND SAFETY COMMITTEE 1986-1987 J. Ronald Condray, Monsanto Company, Chairman George A. Rodenhausen, Celanese Corporation, Vice Chairman Robert F. Brothers, Eastman Kodak Company Joseph C. Caporossi, American Cyanamid Company Raymond W. Hussey, The Lubrizol Corporation Michael Marshall, Lonza, Inc. James Norwood, Air Products and Chemicals, Inc. Irv Rosenthal, Rohm and Haas Company Mitchell Sauerhoff, Stauffer Chemical Company David Smallwood, ARCO Chemical Company Charles E. Stehr, Shell Chemical Company Gary Sunshine, ICI Americas, Inc. Gary Ter Haar, Ethyl Corporation Frank Ubel, 3M Company Carl W. Umland, Exxon Chemical Americas BOR 007581 7 Task Group Organization Task Group Biotechnology CAER Exposure Assessment External Affairs Hazard Assessment H alth Programs Information Management Labeling Notification and Reporting Process Safety Analysis Product Management Public Compensation Right-To-Know Risk Assessment Safety Programs Chairman Robert Brothers Joseph Lojewski MichaelJaycock Robert Hagerman James Hathaway Curtis Elmer Thayre Talcott Howard Kreuger Ellis Knowlton/ Robert Ormsby Joseph LeBeau David Sigman Thomas Evans James Bonin Mark Tuohey Sponsor Robert Brothers Michael Marshall Gary Ter Haar Raymond Hussey Mitchell Sauerhoff Frank Ubel Robert Brothers David Smallwood Robert Brothers James Norwood CMA Staff Executiv M. Herz C. Cathcart J. Kelley T. O'Leary M. Herz N. Doerrer L. Ramonas M. Herz N. Doerrer G. Baker K. Olson Gary Ter Haar Charles Stehr James Norwood G. Baker L. Ramonas L. Ramona^ T. O'Leary K. Olson CMA Contact: Randal P. Schumacher, 202/887-1386 00^582 8